ATYR
aTyr Pharma, Inc.
0.3564$
-4.4%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | 3,328.9% | 165.4% | – | 16.3% | 776.5% | 655.3% | 817.4% | |
| – | – | – | – | – | -3,228.9% | -65.4% | – | 83.7% | 100.0% | 100.0% | -717.4% | |
| – | – | – | – | – | 3,328.9% | 165.4% | – | 412.2% | 11,981.0% | 23,137.0% | 31,694.2% | |
| – | – | – | – | – | 2,216.1% | 86.8% | – | 134.6% | 3,676.8% | 5,862.6% | 9,262.1% | |
| – | – | – | – | – | 2,216.1% | 86.8% | – | 530.5% | 15,657.8% | 28,999.6% | 40,138.9% | |
| – | – | – | – | – | -5,445.0% | -152.2% | – | -446.8% | -15,557.8% | -28,899.6% | -40,856.3% | |
| – | – | – | – | – | -5,631.0% | -155.2% | – | -436.6% | -14,276.8% | -27,243.4% | -39,009.5% | |
| – | – | – | – | – | -37.9% | -0.1% | – | 0.0% | -2.3% | – | – | |
| – | – | – | – | – | -5,593.1% | -155.2% | – | -436.5% | -14,274.5% | -27,243.8% | -39,009.5% | |
| – | – | – | – | – | -5,294.5% | -140.1% | – | -420.3% | -13,500.3% | -26,588.1% | -38,192.1% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.